Provided by Tiger Trade Technology Pte. Ltd.

Evolent Health

5.60
+0.12002.19%
Post-market: 5.600.00000.00%19:59 EDT
Volume:1.49M
Turnover:8.23M
Market Cap:629.89M
PE:-1.19
High:5.63
Open:5.30
Low:5.29
Close:5.48
52wk High:12.03
52wk Low:2.10
Shares:112.48M
Float Shares:93.95M
Volume Ratio:0.56
T/O Rate:1.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7089
EPS(LYR):-5.0732
ROE:-65.11%
ROA:-0.45%
PB:1.59
PE(LYR):-1.10

Loading ...

Evolent Health (EVH) Receives a Hold from RBC Capital

TIPRANKS
·
1 hour ago

Evolent Health to Report Q2 2026 Results, Host Conference Call

Reuters
·
6 hours ago

HON, EVH, OC, GLOB, MKSI Trending With Analysts

TIPRANKS
·
Jul 04

Evolent Health Cut to Hold from Buy by Truist Securities

Dow Jones
·
Jun 30

Evolent Health Inc : Truist Securities Cuts to Hold from Buy

THOMSON REUTERS
·
Jun 30

Truist Downgrades Evolent Health to Hold From Buy, Keeps $7 Price Target, Cites Recent Share Price Strength, Medicaid Headwind

MT Newswires Live
·
Jun 30

U.S. Research Roundup- Comcast, Honeywell Aerospace, Qualys

Reuters
·
Jun 30

Evolent Health Is Maintained at Buy by Truist Securities

Dow Jones
·
Jun 12

Truist Raises Price Target on Evolent Health to $7 From $6, Keeps Buy Rating

MT Newswires Live
·
Jun 12

Evolent Health Shareholders Approve Proposals at 2026 Meeting

TIPRANKS
·
Jun 05

Evolent Health shareholders elect 10 directors at annual meeting

Reuters
·
Jun 05

Analysts’ Top Healthcare Picks: ProMIS Neurosciences (PMN), Evolent Health (EVH)

TIPRANKS
·
May 16

Evolent Health Is Maintained at Buy by Citigroup

Dow Jones
·
May 16

Citigroup Adjusts Price Target on Evolent Health to $5.50 From $4, Maintains Buy Rating

MT Newswires Live
·
May 15

Evolent Health Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
May 13

Evolent Health price target raised to $6 from $5 at Canaccord

TIPRANKS
·
May 12

Quest Analytics Expands Leadership Team With Appointment of Chris Lance as Chief Product Officer

THOMSON REUTERS
·
May 12

Press Release: Quest Analytics Expands Leadership Team with Appointment of Chris Lance as Chief Product Officer

Dow Jones
·
May 12

Evolent Health Earnings Call Balances Growth and Risk

TIPRANKS
·
May 09

Evolent Health Is Maintained at Buy by Needham

Dow Jones
·
May 08